Synapse Medicine - Press

Synapse Medicine raises $28M to scale its medication reconciliation platform

01 Mar 2022

Synapse Medicine raises $28M to scale its medication reconciliation platform

Synapse Medicine has raised $28 million, led by leading European venture firm Korelya Capital, and past investors (XAnge...

Synapse Medicine Expands Its European Medication Reconciliation Business to the United States.

26 Oct 2021

Synapse Medicine Expands Its European Medication Reconciliation Business to the United States.

Synapse Medicine, the leading Medication Intelligence platform, today announced plans to provide American healthcare pro...

Synapse Medicine and Dedalus partner on Medication Reconciliation

28 Sep 2021

Synapse Medicine and Dedalus partner on Medication Reconciliation

Synapse Medicine, the leading Medication Intelligence technology, announces a partnership on medication reconciliation w...

COVID-19 vaccination campaign safety : France rolls out the "Medication Shield" of Synapse Medicine.

19 Aug 2021

COVID-19 vaccination campaign safety : France rolls out the "Medication Shield" of Synapse Medicine.

Synapse Medicine, which was founded by public health physicians, rolls out its Medication Shield technology to increase ...

Synapse Medicine raises 8 million dollars to prevent drug-related risks everywhere in the world

06 Jul 2020

Synapse Medicine raises 8 million dollars to prevent drug-related risks everywhere in the world

Synapse Medicine has announced that it has raised 8 million dollars, spearheaded by the MACSF, a leading insurance provi...

They talk about us

Synapse Medicine enters clinical trial for COVID-19

Synapse Medicine enters clinical trial for COVID-19

Covid-19: A clinical trial evaluates four treatments in patients at home

Covid-19: A clinical trial evaluates four treatments in patients at home

Covid-19: in Bordeaux, the Coverage clinical trial treats people over 65 at home

Covid-19: in Bordeaux, the Coverage clinical trial treats people over 65 at home

A large outpatient and early disease clinical trial to evaluate four drugs

A large outpatient and early disease clinical trial to evaluate four drugs